Physician

Charles Peter Busse, M.D.

According to 2025 Medicare claims, Charles Busse, M.D. (NPI: 1477590594) practices family practice in the Myrtle Beach-Conway-North Myrtle Beach, SC market, with the plurality of this provider's patient population coming from Horry, SC. This provider's primary affiliated billing organization is SC HOUSE CALLS INC (NPI: 1518048859; TIN: 205227543) and primary practice location at 29572-4634. Busse is affiliated with the Advanced Illness Partners, LLC (ACO ID: D0097), participating under the REACH model.

Busse's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 511 traditional Medicare patients, billed 6,369 HCPCS/CPT codes, and received $372,835 in Medicare payments. The top billing code was 99487 (Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month). Part D data shows 3,333 prescription claims across 452 beneficiaries totaling $245,197 in drug costs, led by Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen). 2023 DME data shows 24 claims. Open Payments data shows 16 records totaling $450. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $161,578 to $372,835. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $442,132 to $245,197. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $48,552 to $4,929.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	527	2,476	$161,578
2016	563	1,350	$79,190
2017	388	650	$39,487
2018	323	565	$33,713
2019	532	764	$50,097
2020	559	1,052	$50,594
2021	639	1,223	$54,297
2022	92	169	$9,427
2023	235	3,725	$226,145
2024	511	6,369	$372,835

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	526	6,543	$442,132
2016	445	8,435	$585,253
2017	351	5,160	$311,092
2018	178	1,566	$96,511
2019	272	3,095	$154,625
2020	117	1,156	$52,410
2021	279	1,056	$58,578
2022	162	568	$36,627
2023	323	1,101	$66,366
2024	452	3,333	$245,197

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	194	716	$38,471
2016	150	907	$88,107
2017	N/R	330	$16,786
2018	N/R	72	$10,382
2019	N/R	32	$5,976
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	11	$1,006
2023	N/R	24	$4,798
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99487	Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month	257	785	$99
99349	Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes	222	277	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	139	173	$66
99489	Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month	239	3,619	$53
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	150	376	$45

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	688	20,324	$31,860
Ozempic	Semaglutide	21	686	$20,914
Eliquis	Apixaban	24	1,020	$19,398
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	452	13,229	$15,712
Mounjaro	Tirzepatide	12	336	$12,860

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$450	Phathom Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles Peter Busse, M.D.?

Tedicare shows public-source Medicare data for Charles Peter Busse, M.D. (NPI 1477590594), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Peter Busse, M.D. have ACO affiliation data?

Charles Peter Busse, M.D. is shown with ACO affiliation data for Advanced Illness Partners, LLC (REACH, ACO ID D0097).

What billing organization is linked to Charles Peter Busse, M.D.?

Charles Peter Busse, M.D. is linked to SC HOUSE CALLS INC (billing NPI 1518048859) in the available physician profile data.

Does Charles Peter Busse, M.D. have Open Payments data?

Charles Peter Busse, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.